Header cover image
  • Investing Ideas
  • Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Gubra

Market Cap: DKK 5.4b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

GUBRA

DKK 322.20

7D

-0.6%

1Y

-25.1%